Michael R. Rose

How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

C.A.C. Prinsen, Sunita Vohra, Michael R. Rose et al. · Trials · 2016 · 1.1K citations · Full text

Medicine, Health Policy, Comparative Effectiveness Research +15

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

Jessica E. Hoogendijk, Anthony A. Amato, Bryan Lecky et al. · Neuromuscular Disorders · 2004 · 937 citations

Medicine, Internal Medicine, Autoimmunity +11

188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands

Michael R. Rose · Neuromuscular Disorders · 2013 · 387 citations · Full text

Medicine, Internal Medicine, Orthopedic Surgery +10

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

Carolyn T. Bramante, John B. Buse, David Liebovitz et al. · The Lancet Infectious Diseases · 2023 · 223 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +5

Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies

Haiyan Zhou, Heinz Jungbluth, C. Sewry et al. · Brain · 2007 · 177 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15